Tumor-infiltrating lymphocytes for treatment of solid tumors: It takes two to tango?
Tumor-infiltrating lymphocytes (TILs), frontline soldiers of the adaptive immune system, are
recruited into the tumor site to fight against tumors. However, their small number and …
recruited into the tumor site to fight against tumors. However, their small number and …
Dendritic cells as orchestrators of anticancer immunity and immunotherapy
I Heras-Murillo, I Adán-Barrientos, M Galán… - Nature Reviews …, 2024 - nature.com
Dendritic cells (DCs) are a heterogeneous group of antigen-presenting innate immune cells
that regulate adaptive immunity, including against cancer. Therefore, understanding the …
that regulate adaptive immunity, including against cancer. Therefore, understanding the …
A nanoadjuvant that dynamically coordinates innate immune stimuli activation enhances cancer immunotherapy and reduces immune cell exhaustion
Although conventional innate immune stimuli contribute to immune activation, they induce
exhausted immune cells, resulting in suboptimal cancer immunotherapy. Here we suggest a …
exhausted immune cells, resulting in suboptimal cancer immunotherapy. Here we suggest a …
Iron oxide nanoparticle targeted chemo-immunotherapy for triple negative breast cancer
Triple negative breast cancer (TNBC) is difficult to treat effectively, due to its aggressiveness,
drug resistance, and lack of the receptors required for hormonal therapy, particularly at the …
drug resistance, and lack of the receptors required for hormonal therapy, particularly at the …
Type I and II interferons in the anti-tumor immune response
Simple Summary Interferons are cytokines that play key roles in the activation of cellular
components of the immune response, such as dendritic cells, macrophages and T cells …
components of the immune response, such as dendritic cells, macrophages and T cells …
Dendritic cells and cancer immunotherapy: The adjuvant effect
S Nava, D Lisini, S Frigerio, A Bersano - International Journal of …, 2021 - mdpi.com
Dendritic cells (DCs) are immune specialized cells playing a critical role in promoting
immune response against antigens, and may represent important targets for therapeutic …
immune response against antigens, and may represent important targets for therapeutic …
Immunotherapeutic implications of toll-like receptors activation in tumor microenvironment
R Zheng, J Ma - Pharmaceutics, 2022 - mdpi.com
Toll-like receptors (TLRs) play an important role between innate and adaptive immunity as
one of the pattern recognition receptors (PRRs). Both immune cells and tumor cells express …
one of the pattern recognition receptors (PRRs). Both immune cells and tumor cells express …
Clinical and molecular insights into BCG immunotherapy for melanoma
M Kremenovic, M Schenk… - Journal of internal …, 2020 - Wiley Online Library
The incidence of cutaneous melanoma and the mortality rate of advanced melanoma
patients continue to rise globally. Despite the recent success of immunotherapy including …
patients continue to rise globally. Despite the recent success of immunotherapy including …
[HTML][HTML] A T-cell-based immunogenicity protocol for evaluating human antigen-specific responses
CC Bozkus, AB Blazquez, T Enokida, N Bhardwaj - STAR protocols, 2021 - Elsevier
Determining the antigen specificities of the endogenous T-cell repertoire is important for
screening naturally occurring or therapy-induced T-cell immunity and may help identify …
screening naturally occurring or therapy-induced T-cell immunity and may help identify …
[HTML][HTML] Combinations of Toll-like receptor 8 agonist TL8-506 activate human tumor-derived dendritic cells
M He, B Soni, PC Schwalie, T Hüsser… - … for Immunotherapy of …, 2022 - ncbi.nlm.nih.gov
Background Dendritic cells (DCs) are professional antigen presenting cells that initiate
immune defense to pathogens and tumor cells. Human tumors contain only few DCs that …
immune defense to pathogens and tumor cells. Human tumors contain only few DCs that …